MD News

Bellicum Announces Publication in The New England Journal of Medicine ...
PR Newswire (press release)
CaspaCIDeā„¢ DLI is a donor lymphocyte infusion administered following a hematopoietic stem cell transplant, in which the safety switch may be activated to resolve graft-versus-host disease (GVHD). For more information, visit www.bellicum.com.
Bellicum Announces Publication in The New England Journal of Medicine ...istockAnalyst.com (press release)

all 12 news articles »